MEND: Funding, Investors & Team (Oct 2026)
MEND is a company focused on life sciences, determined to assist individuals in achieving better health through healing. The company's focus is on developing personalized medical food interventions and clinical nutrition to improve outcomes for patients dealing with injury or surgery, those who are aging, and those who engage in physical activities. MEND has garnered interest from many hospitals, healthcare systems, professional sports teams in all major leagues, and the top forces within the US Military.
MEND has raised $47.0M across 4 funding rounds on record, the most recent a Series A of $20.0M announced in Dec 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MEND Company Profile and Key Stats
Latest funding round on record: Dec 2025.
MEND Funding Rounds
MEND raised $10.5M in an undisclosed round announced in Apr 2023.
2 months later, a Series A of $15.0M was announced in Jun 2023.
2 years later, an undisclosed round of $1.5M was announced in Jun 2025.
6 months later, a Series A of $20.0M was announced in Dec 2025.
MEND Founders and Leadership Team
Contact details for the MEND team: 1 of 2 have an email address on file.
Start 14-day free trial →MEND Funding Compared to Other Biotechnology Startups
MEND's latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MEND in Biotechnology and New York
Companies Similar to MEND
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
MEND Funding FAQs
What does MEND do?
MEND is a company focused on life sciences, determined to assist individuals in achieving better health through healing. The company's focus is on developing personalized medical food interventions and clinical nutrition to improve outcomes for patients dealing with injury or surgery, those who are aging, and those who engage in physical activities. MEND has garnered interest from many hospitals, healthcare systems, professional sports teams in all major leagues, and the top forces within the US Military.
How much funding has MEND raised?
MEND has raised $47.0M across 4 rounds on record. The most recent is a Series A of $20.0M announced in Dec 2025.
When did MEND last raise funding?
MEND's most recent funding round on record is a Series A of $20.0M, announced in Dec 2025.
Who founded MEND?
FundedIQ lists Eziah Syed (Founder), J Whitney Stevens (Founder) at MEND.
Where is MEND headquartered?
MEND is based in New York, United States.
How many employees does MEND have?
MEND is in the 11-50 employee band.
How does MEND's funding compare to other Biotechnology startups?
MEND's latest round of $20.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's MEND Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MEND is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.